DE69731985D1 - Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren - Google Patents

Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren

Info

Publication number
DE69731985D1
DE69731985D1 DE69731985T DE69731985T DE69731985D1 DE 69731985 D1 DE69731985 D1 DE 69731985D1 DE 69731985 T DE69731985 T DE 69731985T DE 69731985 T DE69731985 T DE 69731985T DE 69731985 D1 DE69731985 D1 DE 69731985D1
Authority
DE
Germany
Prior art keywords
manufacturing process
spare parts
suitable conjugation
blank spare
blank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69731985T
Other languages
English (en)
Other versions
DE69731985T2 (de
Inventor
David Heath
Sarah Margaret Middleton
Roy Harris
Nicola Jane Church
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Quadrant Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26310263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69731985(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9621886.2A external-priority patent/GB9621886D0/en
Priority claimed from GBGB9702652.0A external-priority patent/GB9702652D0/en
Application filed by Quadrant Drug Delivery Ltd filed Critical Quadrant Drug Delivery Ltd
Publication of DE69731985D1 publication Critical patent/DE69731985D1/de
Application granted granted Critical
Publication of DE69731985T2 publication Critical patent/DE69731985T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
DE69731985T 1996-10-21 1997-10-17 Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren Expired - Lifetime DE69731985T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9621886.2A GB9621886D0 (en) 1996-10-21 1996-10-21 Microparticles and their therapeutic use
GB9621886 1996-10-21
GB9702652 1997-02-10
GBGB9702652.0A GB9702652D0 (en) 1997-02-10 1997-02-10 Conjugates and their preparation
PCT/GB1997/002877 WO1998017319A2 (en) 1996-10-21 1997-10-17 Platelet substitutes and conjugation methods suitable for their preparation

Publications (2)

Publication Number Publication Date
DE69731985D1 true DE69731985D1 (de) 2005-01-20
DE69731985T2 DE69731985T2 (de) 2005-12-29

Family

ID=26310263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731985T Expired - Lifetime DE69731985T2 (de) 1996-10-21 1997-10-17 Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren

Country Status (10)

Country Link
US (1) US5977313A (de)
EP (1) EP1028752B1 (de)
JP (1) JP2001504813A (de)
AR (1) AR008680A1 (de)
AT (1) ATE284714T1 (de)
AU (1) AU718956B2 (de)
CA (1) CA2269335C (de)
DE (1) DE69731985T2 (de)
ES (1) ES2232862T3 (de)
WO (1) WO1998017319A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
CA2294494A1 (en) 1997-06-05 1998-12-10 Richard C. K. Yen Fibrinogen-coated microspheres
GB9724143D0 (en) 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
EP1056484A1 (de) * 1998-02-20 2000-12-06 Quadrant Healthcare (UK) Limited Fibrinogen enthaltende produkte zur verwendung in therapie
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
GB9827813D0 (en) * 1998-12-17 1999-02-10 Andaris Ltd Pharmaceutical conjugates
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
DE10135356C1 (de) * 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
AU2002330139A1 (en) * 2001-10-03 2003-04-14 Vanderbilt University In vivo panning for ligands to radiation-induced molecules
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
GB0323378D0 (en) 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
GB0516091D0 (en) * 2005-08-04 2005-09-14 Haemostatix Ltd Therapeutic agent
US20080015145A1 (en) * 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
WO2009140598A1 (en) * 2008-05-16 2009-11-19 Bayer Healthcare Llc Targeted coagulation factors and method of using the same
WO2010136588A2 (en) 2009-05-28 2010-12-02 Profibrix B.V. Dry powder fibrin sealant
GB201101740D0 (en) * 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
GB201201751D0 (en) 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
GB201204868D0 (en) 2012-03-20 2012-05-02 San Raffaele Centro Fond Peptides
EP3172222A4 (de) 2014-07-24 2018-03-21 Washington University Gegen strahlungsinduzierte moleküle gerichtete zusammensetzungen und verfahren zur verwendung davon
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
AU2016307447A1 (en) 2015-08-07 2018-02-22 Xcede Technologies, Inc. Adhesive compositions and related methods
CN107686508B (zh) * 2016-08-05 2021-02-12 首都医科大学 阿霉素-rgds,其合成,活性和应用
CN107686507B (zh) * 2016-08-05 2021-02-12 首都医科大学 Rgds-阿霉素,其合成,活性和应用
EP3634459A4 (de) 2017-02-10 2021-01-06 Washington University Antikörper gegen tip1 und verfahren zur verwendung davon

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4661471A (en) * 1984-04-10 1987-04-28 New England Deaconess Hospital Method of inhibiting and inducing human platelet aggregation
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US5069936A (en) * 1987-06-25 1991-12-03 Yen Richard C K Manufacturing protein microspheres
AU3149289A (en) * 1988-03-18 1989-09-21 Rockefeller University, The Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor
WO1990003401A1 (en) * 1988-09-30 1990-04-05 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
EP0494417B1 (de) * 1991-01-10 1996-04-17 Basf Corporation Verfahren zur Vernetzen von Gelatine und Aufnahme eines Materials
DK0495187T3 (da) * 1991-01-15 1997-08-11 Hemosphere Inc Protein-nanomatricer og fremstillingsmetode.
WO1996039128A1 (en) * 1995-06-06 1996-12-12 Hemosphere, Inc. Protein particles for therapeutic and diagnostic use
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
US5725804A (en) * 1991-01-15 1998-03-10 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
WO1992013547A1 (en) * 1991-02-07 1992-08-20 Alexander Mellon Eaton Drug delivery composition and method of using the same
WO1992013495A1 (en) * 1991-02-07 1992-08-20 Fibratek, Inc. Fibrinogen based adhesive
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
WO1994013692A1 (en) * 1992-12-10 1994-06-23 Regents Of The University Of Minnesota Polypeptides useful for treating inflammatory disorders
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
ES2191721T3 (es) * 1994-12-16 2003-09-16 Elan Drug Delivery Ltd Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos.
EP0727225A3 (de) * 1995-02-14 1997-01-15 Sonus Pharma Inc Zusammensetzungen und Verfahren zur Herstellung von gerichteter Ultraschallabbildung

Also Published As

Publication number Publication date
AR008680A1 (es) 2000-02-09
ES2232862T3 (es) 2005-06-01
AU718956B2 (en) 2000-05-04
AU4713597A (en) 1998-05-15
EP1028752A2 (de) 2000-08-23
JP2001504813A (ja) 2001-04-10
EP1028752B1 (de) 2004-12-15
US5977313A (en) 1999-11-02
WO1998017319A2 (en) 1998-04-30
ATE284714T1 (de) 2005-01-15
CA2269335C (en) 2010-05-25
CA2269335A1 (en) 1998-04-30
DE69731985T2 (de) 2005-12-29
WO1998017319A3 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
DE69731985D1 (de) Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren
DE69730512D1 (de) Fahrzeugradanordnung und herstellungsverfahren
DE69524215T2 (de) Retroreflektierender körper und herstellungsverfahren
DE69531373D1 (de) Induktivität und zugehöriges Herstellungsverfahren
DE69808948D1 (de) Stossfänger und herstellungsverfahren
DE69736151D1 (de) Photovoltaische Anordnung und Herstellungsverfahren
DE69929456D1 (de) Nahfeldabtastkopf und herstellungsverfahren
DE69615437T2 (de) Integrierte Schaltungsanordnung und Herstellungsverfahren
DE69427919T2 (de) Doppelrilliger retroreflektiver würfeleckiger körper und herstellungsverfahren
DE69522846D1 (de) Verbesserte Speicheranordnung und Herstellungsverfahren
DE69730775D1 (de) Logische Schaltung und zugehöriges Herstellungsverfahren
DE59811973D1 (de) Optisches Glied und Herstellverfahren
DE69504262T2 (de) Halbleiterlaser und dessen Herstellungsverfahren
DE69712541T2 (de) Halbleiterlaser und Herstellungsverfahren
DE69714370T2 (de) Verbesserte Lenkradform und Formverfahren
ID16410A (id) Proses produksi lipstatin dan tetrahidrolipstatin
HUP9802956A3 (en) Granulate and process for manufacturing the same
DE69718223T2 (de) Massenspeicher und Herstellungsverfahren dafür
DE59813718D1 (de) Kondensatoranordnung und Herstellungsverfahren
DE69519363D1 (de) Schokolade mit niedrigem Erweichungspunkt und Herstellungsverfahren
DE19781531T1 (de) Drosselkörper und Herstellungsverfahren dafür
DE69627206D1 (de) Düse und Düsenherstellungsverfahren
DE69714052D1 (de) Fahrzeugrahmen und herstellungsverfahren
DE69635476D1 (de) Kondensator und Herstellungsverfahren
DE69510007D1 (de) Gleitteil und Herstellungsverfahren

Legal Events

Date Code Title Description
8363 Opposition against the patent